Skip to content

US · SDGR · SOFTWARE - APPLICATION

Schrödinger, Inc. (SDGR) intrinsic value and stock valuation

$22.93as of 2026-11-21 · Mkt cap 1.23B

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Schrödinger, Inc. DCF and intrinsic value

InvestorsCraft values SDGR with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from SDGR’s statements →

Schrödinger, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Technology · Software - Application New York, NY 10036 schrodinger.com

How the business is doing

Fiscal 2017–2025, USD

Revenue
$255.9M+18.8% 5y CAGRd
20172025
Net income
-$-103.27M
20172025
Free cash flow
$12.5M-2.6% 5y CAGRd
20172025
Total equity
$364.1M-10.2% 5y CAGRd
20172025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2017–2025, USD
20252024202320222021
Revenue$255.9M$207.5M$216.7M$181M$137.9M
Operating income-$-166.9M-$-209.3M-$-177.45M-$-146.82M-$-111.44M
Net income-$-103.27M-$-187.12M$40.7M-$-149.19M-$-100.39M
EPSd-$-1.41M-$-2.57M$543K-$-2.1M-$-1.42M
Operating cash flow$13.9M-$-157.37M-$-136.73M-$-119.68M-$-70.67M
Capital expenditure-$-1.44M-$-7.31M-$-13.4M-$-8.01M-$-7.17M
Free cash flow$12.5M-$-164.68M-$-150.14M-$-127.7M-$-77.84M
Total assets$726.2M$823.2M$803M$688.6M$756.5M
Total debt$109.2M$117.8M$127.9M$116.5M$79.9M
Net debt-$-121.29M-$-29.5M-$-27.43M$26M-$-40.4M
Total equity$364.1M$421.4M$548.6M$447.9M$557.1M
Cash and short-term investments$395.5M$352.1M$463M$451.1M$576.5M
Income statement
20252024202320222021
Revenue$255.9M$207.5M$216.7M$181M$137.9M
Cost of revenue$113.3M$75.5M$76M$79.9M$72.3M
Gross profit$142.6M$132.1M$140.7M$101M$65.6M
Research and development expenses$173.1M$201.8M$181.8M$126.4M$90.9M
Selling, general and administrative expenses$136.4M$139.6M$136.4M$121.5M$86.2M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$309.5M$341.4M$318.1M$247.8M$177.1M
Cost and expenses$422.8M$416.8M$394.1M$327.8M$249.4M
Interest income$0.00$0.00$0.00$3.95M$1.06M
Interest expense$0.00$0.00$0.00$0.00$0.00
Depreciation and amortization$6.02M$6.16M$5.55M$4.34M$2.85M
Ebitda-$-96.3M-$-179.55M$48.5M-$-144.78M-$-97.96M
Operating income-$-166.9M-$-209.3M-$-177.45M-$-146.82M-$-111.44M
Total other income/expenses, net$64.6M$23.6M$220.4M-$-2.31M$10.6M
Income before tax-$-102.33M-$-185.71M$42.9M-$-149.12M-$-100.81M
Income tax expense$940K$1.41M$2.2M$60K$410K
Net income-$-103.27M-$-187.12M$40.7M-$-149.19M-$-100.39M
Weighted average shares outstanding$73.4M$72.7M$71.8M$71.2M$70.6M
Weighted average diluted shares outstanding$73.4M$72.7M$75M$71.2M$70.6M
Balance sheet
20252024202320222021
Cash and short-term investments$395.5M$352.1M$463M$451.1M$576.5M
Net receivables$104.4M$255.3M$89.1M$69.1M$40.6M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$519.3M$635M$567.8M$534M$625.1M
Property, plant and equipment, net$122.2M$136.1M$141.1M$120.2M$85.4M
Goodwill and intangible assets$4.79M$4.79M$4.79M$5.38M$0.00
Long-term investments$73.7M$43.2M$83.3M$25.7M$43.2M
Total non-current assets$206.9M$188.2M$235.2M$154.6M$131.4M
Total assets$726.2M$823.2M$803M$688.6M$756.5M
Accounts payable$11.5M$10.7M$16.8M$9.47M$8.08M
Short-term debt$16.4M$16.8M$16.9M$11M$2.04M
Deferred revenue$112.9M$111.9M$56.2M$57.9M$55.4M
Total current liabilities$189.1M$191.8M$133.7M$108.8M$91.2M
Long-term debt$92.8M$101.1M$111M$105.5M$77.8M
Deferred revenue, non-current$78.9M$108.8M$9.04M$25.6M$30.1M
Total non-current liabilities$173M$210M$120.7M$131.9M$108.2M
Capital lease obligations$92.8M$117.8M$127.9M$116.5M$79.9M
Total liabilities$362.1M$401.8M$254.4M$240.7M$199.4M
Common stock$650K$730K$720K$710K$710K
Retained earnings-$-628.81M-$-525.54M-$-338.42M-$-379.14M-$-229.95M
Accumulated other comprehensive income (loss)$110K$220K$280K-$-2.38M-$-650K
Total equity$364.1M$421.4M$548.6M$447.9M$557.1M
Total investments$238.6M$248M$390.9M$386.3M$499.4M
Total debt$109.2M$117.8M$127.9M$116.5M$79.9M
Net debt-$-121.29M-$-29.5M-$-27.43M$26M-$-40.4M
Cash flow statement
20252024202320222021
Net income-$-103.27M-$-187.12M$40.7M-$-149.19M-$-101.22M
Depreciation and amortization$6.02M$6.16M$5.55M$4.34M$2.85M
Stock-based compensation$43M$49.9M$47.8M$39.6M$26.5M
Change in working capital$118.2M-$-13.04M-$-22.55M-$-21.38M$4.68M
Accounts receivable$150.9M-$-166.22M-$-20.03M-$-27.95M-$-5.51M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$910K-$-6.12M$7.32M$1.18M-$-410K
Net cash provided by operating activities$13.9M-$-157.37M-$-136.73M-$-119.68M-$-70.67M
Investments in property, plant and equipment-$-1.44M-$-7.31M-$-13.4M-$-8.01M-$-7.17M
Acquisitions, net$0.00$45.7M-$-4.12M-$-7.03M$0.00
Net cash used for investing activities$57.9M$148.8M$193M$90M-$-16.81M
Common stock issued$2.99M$8.87M$0.00$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$2.93M$10.1M$9.05M$2.11M$7.95M
Net change in cash$74.7M$1.59M$65.4M-$-27.55M-$-79.53M
Cash at end of period$237.4M$162.7M$161.1M$95.7M$123.3M
Operating cash flow$13.9M-$-157.37M-$-136.73M-$-119.68M-$-70.67M
Capital expenditure-$-1.44M-$-7.31M-$-13.4M-$-8.01M-$-7.17M
Free cash flow$12.5M-$-164.68M-$-150.14M-$-127.7M-$-77.84M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Schrödinger, Inc.

        Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

        CEO
        Ramy Farid
        Employees
        850
        Beta
        1.62

        Explore

        Frequently asked questions

        What is the intrinsic value of Schrödinger, Inc. (SDGR)?

        Schrödinger, Inc. (SDGR) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is SDGR undervalued?

        SDGR trades at a price of $22.93 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.